I. Purpose

Pfizer Medical Education Group (PMEG) and The Joint Commission are collaborating to offer a new grant opportunity focused on antimicrobial stewardship. The goal of this request for proposals (RFPs) is to accelerate the development and adoption of evidence-based approaches that have the capacity to prevent or contain antimicrobial resistance (AMR), and that support and promote appropriate use of antimicrobial agents. This collaboration will drive efforts to improve patient outcomes and slow AMR. This grant mechanism will support the development, testing and implementation of sustainable antimicrobial stewardship strategies and programs that can be shown to contain and prevent antimicrobial resistance in: acute care hospitals (academic medical centers and community based hospitals); long term care facilities; ambulatory care facilities and other out-patient settings. For the purpose of this RFP antimicrobial stewardship is defined as a systematic, evidence-based approach to the use of antimicrobial agents in order to achieve optimal outcomes. This entails using the right agent, at the correct dose, administered by the correct route and for th